References
- Tanaka K, Kaneko T. Action of 4′-ethyl-2-methyl-3-piperidinopropiophenone on experimental rigidity and spinal cord. Folia Pharmacol Jpn 1981; 77:511–520.
- Fujioka M, Kuriyama H. Eperisone, an antispastic agent, possesses vasodilating actions on the guinea-pig basilar artery. J Pharmacol Exp Ther 1985; 235:757–763.
- Buckley NA, Dawson AW, Whyte IM, O’Connell DL. Relative toxicity of benzodiazepines in overdose. BMJ 1995; 310:219–221.
- Tanno K, Narimatsu E, Takeyama Y, Asai Y. Infantile case of seizure induced by intoxication after accidental consumption of eperizone hydrochloride, an antispastic agent. Am J Emerg Med 2007; 25:481–482.
- Zareba W, Lin DA. Antipsychotic drugs and QT interval prolongation. Psychiatr Q 2003; 74:291–306.
- Novales-Li P, Sun XP, Takeuchi H. Suppression of calcium current in a snail neurone by eperisone and its analogues. Eur J Pharmacol 1989; 168:299–305.
- Saegusa K, Furukawa Y, Akahane K, Haniuda M, Chiba S. Anti-nicotinic and anti-muscarinic actions of eperisone in the isolated cainine atrium. Jpn J Pharmacol 1991; 56:187–193.
- Moss AJ. The QT interval and torsades de pointes. Drug Saf 1999; 21:81–87.
- Mihara K, Matsumura M, Yoshioka E, Hanada K, Nakasa H, Ohmori S, Kitada M, Ogata H. Intestinal first-pass metabolism of eperisone in the rat. Pharm Res 2001; 18:1131–1137.
- Salhanick SD, Shannon MW. Management of calcium channel antagonist overdose. Drug Saf 2003; 26:65–79.